1 May 2020

DBcaps® capsules factsheet

A complete line of capsules uniquely designed for double blind trials

名字姓氏企业邮箱 Company Name 国家/地区

国家/地区代码

加入我们的社群，获取定制化行业洞察与资源。您可以随时取消订阅。

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content

Latest briefing from the Knowledge Center

Celebrating the 25th Anniversary of UC-II

Over the last 25 years, UC‑II® undenatured type II collagen has redefined the joint health category since its introduction to the…

网络研讨会

A New Era of Enteric Delivery

Capsugel® Enprotect® capsules offer robust gastro resistance and predictable intestinal release, without any coating. In this…

Peer-reviewed publication

A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsules

Oral delivery of glucagon-like peptide-1 (GLP-1) peptides has the potential to improve patient convenience and adherence, but…

Advancing Oral Biologic Delivery: Overcoming Barriers to Enable Innovation and Innovation

Dr Vincent Jannin considers the advantages of delivering biologic medications, including glucagon-like peptide-1s, via oral…

Powered by Translations.com GlobalLink Web Software